← Leaderboards
Veronica Minsu Hong
University Of Texas Dallas
$129,637
Attributed
$129,637
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45.1K · FY2023–25$50K$37.5K$25K$12.5K$0
'23
'24
'25
Funding mix
By agency
NIH$129,637 · 1
By mechanism
F31$129,637 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Dallas
Same institution · by research overlap
- Gregory O Dussor$6,397,705
- Benedict J Kolber$5,284,567
- Joseph J. Pancrazio$3,792,747
- Lakeisha Lewter$209,964
- Munmun Chattopadhyay$945,409
Others in their field
Other Rising Stars on “Acute Pain”
- Taleen Hanania · Psychogenics, Inc.$9,482,040
- Jacob Sutton Coverstone · Neurovations$6,882,205
- John Paderi John Paderi John Paderi · Ihp Therapeutics, Inc.$6,183,017
- Jamie P. Dwyer · University Of Utah$3,602,777
- Matt Devalaraja · Protean Bio Inc.$2,995,006
- Andrea Zawacki Beaton · Cincinnati Childrens Hosp Med Ctr$2,715,661
Research focus
Acute PainAffectAffinity ChromatographyAgonistAnatomyAnimal BehaviorAntagonistBehaviorBehavioralBehavioral PharmacologyBiologicalBiological ProcessCalciumCalcium SignalingCareerCell MembraneCell PhysiologyCellsCell TypeCholesterol HomeostasisChronic Inflammatory PainChronic PainClinicAbuse Liability
Grant awards (3)
Sigma 2 Receptor (TMEM97): Investigating the Peripheral Role of this Novel Therapeutic Target for Pain$41,070
F31 · FY2025 · NS · contact PI
Sigma 2 Receptor (TMEM97): Investigating the Peripheral Role of this Novel Therapeutic Target for Pain$45,144
F31 · FY2024 · NS · contact PI
Sigma 2 Receptor (TMEM97): Investigating the Peripheral Role of this Novel Therapeutic Target for Pain$43,423
F31 · FY2023 · NS · contact PI